(Q37291604)

19 August 2017

1 reference

title

The danger of in-kind drug donations to the Global Fund (English)

1 reference

19 August 2017

Brook K Baker

1

1 reference

19 August 2017

Eva Ombaka

series ordinal

2

1 reference

19 August 2017

language of work or name

English

0 references

publication date

8 October 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

373

1 reference

19 August 2017

issue

9670

1 reference

19 August 2017

page(s)

1218-1221

1 reference

A political analysis of corporate drug donations: the example of Malarone in Kenya

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961487-7

7 January 2021

Entry decisions in the generic pharmaceutical industry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961487-7

7 January 2021

Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961487-7

7 January 2021

The ongoing regulation of generic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961487-7

7 January 2021

The pharmaceutical industry as a medicines provider

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961487-7

7 January 2021

HIV/AIDS drugs for Sub-Saharan Africa: how do brand and generic supply compare?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961487-7

7 January 2021

Pricing of drugs and donations: options for sustainable equity pricing

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961487-7

7 January 2021

10.1016/S0140-6736(08)61487-7

Identifiers

DOI

1 reference

19 August 2017

1 reference